Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors

Figure 1

Summary of AMD clinical evolution adapted from the Beckmann classification system [42] and treatment modalities. AMD: age-related macular degeneration; CNV: choroidal neovascularization; GA: geographic atrophy; IVT: intravitreal injections; VEGF: vascular endothelial growth factor.